MM_Hub: CONGRESS|#EHA2021|Fredrik Schjesvold,also highlighted future treatment direction as more pts will be refractory to current targets at earlier lines. #mmsm, #myeloma Oslo University hospital

by | Jun 12, 2021 | Twitter | 0 comments

CONGRESS|#EHA2021|Fredrik Schjesvold,also highlighted future treatment direction as more pts will be refractory to current targets at earlier lines. #mmsm, #myeloma Oslo University hospital pic.twitter.com/gCgFz64fv7

— Multiple Myeloma Hub (@MM_Hub) June 12, 2021

Submit a Comment